Holen Sie sich die Stockscreener-App
296.30
0.71%
-2.13
Handel nachbörslich:
296.00
-0.30
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$298.43
Offen:
$298.43
24-Stunden-Volumen:
2.75M
Relative Volume:
1.20
Marktkapitalisierung:
$159.52B
Einnahmen:
$34.76B
Nettoeinkommen (Verlust:
$6.62B
KGV:
24.24
EPS:
12.223
Netto-Cashflow:
$10.61B
1W Leistung:
+1.77%
1M Leistung:
-0.53%
6M Leistung:
+5.36%
1J Leistung:
-7.18%
1-Tages-Spanne:
$292.12
$301.00
1-Wochen-Bereich:
$288.00
$301.00
52-Wochen-Spanne:
$253.30
$335.88
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
296.30 | 160.66B | 34.76B | 6.62B | 10.61B | 12.22 |
|
LLY
Lilly Eli Co
|
896.53 | 772.28B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
186.26 | 455.04B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
211.96 | 385.18B | 59.64B | 2.37B | 18.24B | 1.331 |
|
NVS
Novartis Ag Adr
|
123.86 | 237.53B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
82.49 | 214.76B | 63.99B | 19.05B | 14.72B | 7.5596 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
How Amgen Inc. stock compares to growth peersStop Loss & Verified Short-Term Trading Plans - newser.com
Amgen sues Colorado over state’s first-in-the-nation price ceiling on arthritis drug Enbrel - The Daily Gazette
AMD, Arista, Amgen, and more set to report earnings Tuesday - Investing.com
Institutional scanner results for Amgen Inc.Portfolio Growth Summary & Weekly Top Gainers Trade List - newser.com
Amgen Defends Patent For Thyroid Disease Drug At EPO - Law360
Why analysts maintain buy rating on Amgen Inc. (AMG0) stockTrade Volume Report & Technical Entry and Exit Tips - newser.com
US Cancer Immunotherapy Forecast and Company Analysis Report 2025-2033 Featuring Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Pfizer, Novartis, Johnson & Johnson, Eli Lily Co, Seattle GeneticsResearchAndMarkets.com - FinancialContent
Aurdan Capital Management LLC Sells 4,937 Shares of Amgen Inc. $AMGN - MarketBeat
Verity Asset Management Inc. Sells 3,971 Shares of Amgen Inc. $AMGN - MarketBeat
Hunter Associates Investment Management LLC Sells 2,190 Shares of Amgen Inc. $AMGN - MarketBeat
Bank of Montreal Can Cuts Stake in Amgen Inc. $AMGN - MarketBeat
SS&H Financial Advisors Inc. Cuts Position in Amgen Inc. $AMGN - MarketBeat
Burney Co. Acquires 1,157 Shares of Amgen Inc. $AMGN - MarketBeat
Telos Capital Management Inc. Raises Position in Amgen Inc. $AMGN - MarketBeat
How dovish Fed policy supports Amgen Inc. (AMG) stockStop Loss & Daily Stock Trend Reports - newser.com
Wakefield Asset Management LLLP Acquires Shares of 1,974 Amgen Inc. $AMGN - MarketBeat
Plato Investment Management Ltd Increases Position in Amgen Inc. $AMGN - MarketBeat
(AMGN) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Tredje AP fonden Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Lifeworks Advisors LLC Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat
How supply shortages influence Amgen Inc. (AMG) stockWeekly Profit Report & Reliable Volume Spike Trade Alerts - newser.com
Will breakout in Amgen Inc. lead to full recoveryMarket Performance Recap & Fast Exit and Entry Strategy Plans - newser.com
Should I buy Amgen Inc. (AMG0) stock before earnings season2025 Historical Comparison & Growth Oriented Trade Recommendations - newser.com
Will Amgen Inc. (AMG0) stock profit from AI boomMarket Rally & Long-Term Safe Investment Ideas - newser.com
What MACD trends signal for Amgen Inc. (AMG0) stockWeekly Trend Summary & Community Trade Idea Sharing Platform - newser.com
Is Amgen Inc. stock a contrarian buyDay Trade & Verified Entry Point Detection - newser.com
Why global investors buy Amgen Inc. (AMG) stockJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - newser.com
What Fibonacci levels say about Amgen Inc. reboundJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com
Amgen Earnings: What To Look For From AMGN - FinancialContent
What is the fair value estimate for Amgen Inc. (AMG) stock in 2025Weekly Loss Report & Consistent Return Investment Signals - newser.com
What dividend safety score for Amgen Inc. stockGlobal Markets & Long-Term Safe Investment Plans - newser.com
Why global investors buy Amgen Inc. (AMG0) stockEarnings Recap Report & Accurate Technical Buy Alerts - newser.com
Will Amgen Inc. (AMG0) stock recover faster than industryWeekly Risk Report & Capital Efficiency Focused Strategies - newser.com
Longbow Finance SA Takes $7.07 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Maintains Quarterly Dividend of $2.38 Per Share - GuruFocus
Syverson Strege & Co Makes New Investment in Amgen Inc. $AMGN - MarketBeat
AlphaStar Capital Management LLC Acquires New Shares in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Integrity Alliance LLC. - MarketBeat
Will Amgen Inc. (AMG0) stock outperform energy sector in 2025Earnings Summary Report & Breakout Confirmation Alerts - newser.com
Does Amgen Inc. fit your quant trading modelTreasury Yields & AI Powered Market Entry Ideas - newser.com
Amgen Inc. $AMGN Shares Acquired by Mesirow Financial Investment Management Inc. - MarketBeat
Amgen Inc. $AMGN Shares Sold by Spire Wealth Management - MarketBeat
Using flow based indicators on Amgen Inc.2025 Performance Recap & Reliable Intraday Trade Plans - newser.com
Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance
How Amgen’s (AMGN) Dividend and Tezspire Approval Could Shape Investor Expectations for 2025 - simplywall.st
Amgen, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Why Amgen Inc. (AMG) stock could be top winner2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com
Bridgewealth Advisory Group LLC Buys New Shares in Amgen Inc. $AMGN - MarketBeat
Fisher Funds Management LTD Sells 3,315 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Pinnacle Associates Ltd. - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
1.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):